Key Virginia Lawmaker Stable After Heart Attack
- ATHENA post-hoc analysis: less CV death, hospitalization. // Cardiology Today;Jul2009, Vol. 12 Issue 7, p15
The article discusses a post-hoc analysis of the ATHENA trial on the incidence of cardiovascular hospitalizations and death in patients with New York Heart Association (NYHA) III congestive heart failure and/or left ventricular ejection fraction <35% who are assigned to dronedarone, a drug under...
- Changing trends in mortality and admissions to hospital for elderly patients with congestive heart failure in Montreal. Feldman, Debbie Ehrmann; Thivierge, Claude; Guérard, Lise; Déry, Véronique; Kapetanakis, Costas; Lavoie, Gilles; Beck, Eduard J. // CMAJ: Canadian Medical Association Journal;10/16/2001, Vol. 165 Issue 8, p1033
Abstract Background Congestive heart failure (CHF) is a common disease requiring admission to hospital among elderly people and is associated with a high mortality rate. The objective of this study was to examine trends in CHF mortality and admissions to hospital in Montreal between 1990 and...
- Influence of Life-Course Socioeconomic Position on Incident Heart Failure in Blacks and Whites. Roberts, Calpurnyia B.; Couper, David J.; Chang, Patricia P.; James, Sherman A.; Rosamond, Wayne D.; Heiss, Gerardo // American Journal of Epidemiology;Sep2010, Vol. 172 Issue 6, p717
The influence of early-life socioeconomic position (SEP) on incident heart failure in blacks and whites is unknown. The authors examined the relation between early-life SEP and incident, hospitalized heart failure among middle-aged US participants (2,503 black and 8,519 white) in the...
- One Hour of One-on-One Patient Education Reduces Heart
Failure Re-Hospitalization by One Third; Individualized
Pre-Discharge Session Helps Patients Stick to Complex Regimen at
Home. // Ascribe Newswire: Medicine;11/10/2003, p7
A single hour of individualized education before heart failure patients leave the hospital appears to make a major difference in how well they take care of themselves once they get home-and cuts by one-third their risk of returning to the hospital or dying in the next six months. The potential...
- FAST STATS. // Healthcare Purchasing News;Dec2011, Vol. 35 Issue 12, p6
The article presents statistics related to heart failure in the U.S., including statistics on a decline in one year mortality following heart failure, the cost of heart failure in 2010 and the average age of heart failure patients in 2008.
- 331 Comparison of hospital treatment of chronic heart failure among patients with diabetes and without diabetes. Stawicki, S.; Roik, M.; Jasik, M.; Dembe, K.; Tomik, Z.; Scislo, P.; Kochanowski, J.; Karnafel, W.; Opolski, G. // European Journal of Heart Failure. Supplements;Jun2004, Vol. 3 Issue 1, p83
An abstract of the study "Comparison of hospital treatment of chronic heart failure among patients with diabetes and without diabetes," by S. Stawicki and colleagues is presented.
- 409 The likely numbers to come: trends in hospitalisation for heart failure in the ‘sample’ town of trieste and its region. Chersevani, D.; Di Lenarda, A.; Goliani, P.; Grella, M.; Brun, F.; Moretti, M.; Sabbadini, G.; Sinagra, G. // European Journal of Heart Failure. Supplements;Jun2004, Vol. 2 Issue 1, p84
An abstract of the article "The Likely Numbers to Come: Trends in Hospitalisation for Heart Failure in the 'sample' Town of Trieste and Its Region," by D. Chersevani and colleagues, is presented.
- Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN). Komajda, Michel; Lutiger, Beatrix; Madeira, Hugo; Thygesen, Kristian; Bobbio, Marco; Hildebrandt, Per; Jaarsma, Wybren; Riegger, Günter; Rydén, Lars; Scherhag, Armin; Soler-Soler, Jordi; Remme, Willem J. // European Journal of Heart Failure;Jun2004, Vol. 6 Issue 4, p467
Background: Management guidelines for heart failure recommend ACE-I and Î²-blockers. The perception of difficult up-titration might have added to the slow uptake of Î²-blockers despite their mortality and morbidity benefits. Aims: CARMEN offered a possibility to study safety and tolerability...
- 303 Utilization of medications recommended for Chronic Heart Failure and the relationship with annual hospitalization duration in patients over 75 Years. A pharmacoepidemiological study. // European Journal of Heart Failure. Supplements;Jun2005, Vol. 4 Issue 1, p69
An abstract of the study "Utilization of medications recommended for Chronic Heart Failure and the relationship with annual hospitalization duration in patients over 75 Years. A pharmacoepidemiological study," by P. Maison and colleagues is presented.